⌘K

Login Start Free

Home/Filings/4/0001104659-21-089443

4//SEC Filing

Mann Brenda 4

Accession 0001104659-21-089443

CIK 0001372514other

View on SEC.gov Company Profile

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 4:31 PM ET

Size

4.8 KB

Accession

0001104659-21-089443

Insider Transaction Report

Form 4

Period: 2021-07-02

EYEGATE PHARMACEUTICALS INCEYEG

VP of Research & Development

Transactions

Tax Payment
Common Stock
2021-07-02$3.70/sh−154$570→ 15,384 total

Footnotes (1)

[F1]Sale of shares to cover taxes due on restricted stock that vested on 07/01/2021.

Documents

1 file

4
tm2121558d2_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

EYEGATE PHARMACEUTICALS INC

CIK 0001372514

Entity typeother

Related Parties

1

filerCIK 0001668858

Filing Metadata

Form type: 4
Filed: Jul 5, 8:00 PM ET
Accepted: Jul 6, 4:31 PM ET
Size: 4.8 KB

View on SEC.gov